| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-99 | |
| Phytochemical name or plant extracts | (E)-caffeic acid-9-O-β-d-xylpyranosyl-(1→2)-β-d-glucopyranosyl ester | |
| PMID | 29562617 | |
| Literature evidence | The aim of this work was to obtain novel anticancer molecules from D. fragrans, a kind of medicinal plant. | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | Phenylpropanoid | |
| Source of phytochemicals or plant Extracts | Dryopteris fragrans | |
| Geographical availability | Alaska, Alberta, Altay, Amur, British Columbia, Buryatiya, China North-Central, Chita, Finland, Greenland, Inner Mongolia, Irkutsk, Japan, Kamchatka, Khabarovsk, Korea, Krasnoyarsk, Labrador, Magadan, Maine, Manchuria, Manitoba, Michigan, Minnesota, Mongolia, New Brunswick, New Hampshire, New York, Newfoundland, North European Russi, Northwest Territorie, Nova Scotia, Ontario, Primorye, Québec, Sakhalin, Saskatchewan, Tuva, Vermont, West Siberia, Wisconsin, Xinjiang, Yakutskiya, Yukon | |
| Plant parts | Whole plant | |
| Other cancers | Lung cancer, Breast cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | 2.65 ± 0.14 μM against MCF-7 | |
| Potency | Thus, compound 1 can be considered as a promising lead compound and its anticancer mechanism should be further studied. | |
| Cell line/ mice model | A549, MCF-7, SGC7901 , HUVEC | |
| Additional information | NA | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:17095220-1 | |
| Safety | NA |